Last update 06 Jan 2026

HW211026

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
HW211026
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication
Actinic Keratosis
Inactive Indication-
Originator Organization
Wuhan Humanwell Innovative Drug R & D Center Co., Ltd.
Active Organization
Wuhan Humanwell Innovative Drug R & D Center Co., Ltd.Hubei Bio-Pharmaceutical Industrial Technological InstituteHubei Bio-Pharmaceutical Industrial Technological Institute
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with HW211026
CTR20250430
/ CompletedPhase 1
评估HW211026软膏在健康志愿者中单次给药的安全性/耐受性、药代动力学特征的随机、双盲、安慰剂对照、剂量递增的 I 期临床试验
[Translation] A randomized, double-blind, placebo-controlled, dose-escalating Phase I clinical trial to evaluate the safety/tolerability and pharmacokinetic characteristics of a single dose of HW211026 ointment in healthy volunteers
ChiCTR2500097190
/ Not yet recruitingNot ApplicableIIT
To evaluate the safety/tolerability and pharmacokinetics of HW211026 ointment in healthy volunteers after a single administration A randomized, double-blind, placebo-controlled, dose-escalation phase I clinical trial
CTR20254945
/ Not yet recruitingPhase 1
项在光线性角化病患者中评价 HW211026 软膏单/多次给药后的安全性、耐受性、 药代动力学和药效学特征的随机、双盲、安慰剂对照、Ⅰb 期临床试验
[Translation] This is a randomized, double-blind, placebo-controlled, phase Ib clinical trial evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of HW211026 ointment after single/multiple doses in patients with actinic keratosis.
100 Clinical Results associated with HW211026
Login to view more data
100 Translational Medicine associated with HW211026
Login to view more data
100 Patents (Medical) associated with HW211026
Login to view more data
100 Deals associated with HW211026
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Actinic KeratosisPhase 1
China
Wuhan Humanwell Innovative Drug R & D Center Co., Ltd.
05 Mar 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free